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THE EFFECTS OF METHYLPHENIDATE ON THE LEARNING AND
PERFORMANCE OF A CHILD DIAGNOSED ADDH

Kendra Leigh Heath, M.A.
Western Michigan University,

1986

The effects of methylphenidate (Ritalin) on the learning and
performance of a child diagnosed Attention Deficit Disorder with
Hyperactivity (ADDH) was evaluated using a repeated acquisition appa
ratus.

A placebo and three dosages of methylphenidate were evaluated

in both the learning and performance components of the experiment.
Dosages tested included the subject's therapeutic dosage,
5 m g higher, and a dosage 5 m g lower.

a dosage

Methylphenidate produced no

effect of consequence on the number of errors per session, suggesting
that the medication neither impaired nor facilitated learning or
performance at the range of dosages investigated.

Data were also

collected on social behavior in the classroom with the Connor's
Abbreviated Teacher's Rating Scale (CATRS).

No score fell within the

hyperactive range of the scale during the experiment and there was no
consistent dose-dependent effects demonstrated.
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CHAPTER I

INTRODUCTION

The Problem

Attention Deficit Disorder with Hyperactivity (ADDH) is charac
terized by extreme inattentiveness,

impulsivity, distractibility, and

overactivity (American Psychiatric Association,

1980).

Other pos

sible indicators that are seen frequently include academic failure,
conduct disorders,
tionships (Schworm,

lack of motor coordination, and poor peer rela
1982).

Still referred to as hyperkinesis,

hyper-

fitivity, learning disability, or minimal brain dysfunction by many
professionals, the incidence estimates of ADDH vary widely, ranging
from 3% to 20% of all children (Taylor,

1980).

Originating in 1937

when Bradley first documented the use of stimulants as a treatment
for childhood behavior disorders,

stimulant medication is n ow rou

tinely prescribed for the treatment of ADDH (Gan & Cantwell,

1982).

In addition, O'Leary (1980) stated that the use of stimulants in this
manner has increased significantly in the past 20 years.

Gadow

(1981) reported that approximately 1% to 2% of all elementary school
aged children in 1981 were receiving stimulant medication for hyper
activity.
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Effects of Methylphenidate Treatment

Methylphenidate hydrochloride, or Ritalin, appears to be the
preferred drug in both actual clinical use (Gadow,
1980) and research studies (Barkley & Cunningham,

1981;
1978).

O'Leary,
As such,

there exists a plethora of evidence illustrating that methylphenidate
successfully reduces overactivity and impulsivity (Abilcoff & Gittelman, 1985; Brown & Sleator, 1979; Brown, Slimmer, & Wynne,
Sprague & Sleator,

1984;

1977) and increases attentional behavior and

concentration (Abikoff & Gittelman,

1985;

Brown et al.,

1984; Sykes,

Douglas, Weiss, & Minde, 1971; Thurston, Solbol, Swanson, & Kinsbourne,

1979).

Unfortunately,

in studies attempting to determine if

methylphenidate treatment improves academic performance and learning
the results point in the opposite direction.
by Barkley and Cunningham (1978),

In a review conducted

they found that out of 12 short

term studies which examined the impact of methylphenidate on various
academic measures only 3 showed significant improvements, and these
improvements did not occur on every measure used in each study.
Furthermore, the authors of 2 of the 3 studies attributed their
positive results to an increase in attention, not improved achieve
ment

skills

(H. E. Rie, Rie, Stewart, & Ambuel,

1976a,

1976b).

Realistically, it is not surprising to find no improvements in
academic performance during studies that ranged from 2 weeks to 6
months in length as the measures generally used (standardized tests)
were not sensitive enough to detect changes occurring over such a
short time period (Barkley & Cunningham,

1978;

O'Leary,

1980).

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

3
However, long-term research studies also fail to demonstrate academic
improvement as a result of stimulant treatment.

For example, Charles

and Schain (1981) evaluated 62 children 4 years after they had been
diagnosed and treated as hyperactive.

Results from their study

determined that most of the participants (77%) were functioning 2 or
more years below the normal level for their respective age groups on
one or more of the Wide Range Achievement Test (WRAT) and Peabody
Individual Achievement Test (PIAT) subtests.

Teachers' reports indi

cated that 74% were achieving below their grade level in reading,
in math, and 66% were unable to maintain adequate attention.

69%

Also,

34% had repeated one or more grades, 42% were in special classes, and
24% were being tutored.

Only 35% were attending regular classes that

were age appropriate and receiving no support services.

However,

the

lack of a control group for comparison of academic achievement and
placement with the study's participants in addition to the exclusion
of information on the subjects' academic achievement prior to drug
treatment should be considered when the results are interpreted.
Generally,

extensive literature reviews and other long-term studies

support the findings of Charles and Schain (1981) (Barkley & Cunning
ham, 1978; O'Leary, 1980; E. D. Rie & Rie, 1977).
The discrepancy that exists between the effect of methyl
phenidate on hyperactive behaviors (inattentiveness,

impulsiveness,

and constant motion) and its effect on academic performance has
fostered many plausible explanations for its occurrence.

By far the

most widely held explanation is that different doses have varying
effects on different target behaviors (Brown & Sleator,

1979;

" V
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Sleator & Sprague,

1974; Sprague & Sleator,

1977; Walker,

1982).

These studies have shown that the dose which resultB in the m a x i m u m
improvement in social behavior (1.0 mg/kg) impairs academic perform
ance (which is optimally enhanced at 0.3 mg/kg).

Barkley and

Cunningham (1978) provided a novel explanation by suggesting that the
child's age at treatment onset m ay play a significant role in the
documented discrepancy.

They proposes that an older child with a

history of academic difficulties may experience little or no drug
induced academic improvement as the child has probably failed to
learn the basic skills necessary for mastery of more complex ma t e 
rial.

Before any explanation can be widely adopted,

it is clear that

further empirical evidence is needed in this area.
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CHAPTER II

REVIEW OF SELECTED LITERATURE

Most studies of the effects of stimulant medication on academic
performance have looked at academic measures involving only the
recall and application of previously acquired material (Gadow,
Walker,

1982).

1981,

Another area requiring additional investigation con

cerns the effects of stimulants on the rate and ease of acquisition
of n e w material.

Considering the widespread use of stimulants with

school aged children and the potential educational implications of
impairments in learning, it is amazing that more research has not
been conducted to assess the effects of methylphenidate on knowledge
acquisition.

Of the studies that have evaluated this hypothesis,

two

have reported that the stimulants tested had no affect on learning as
measured by paired associate learning tasks (Aman & Sprague,
Connors,

1966).

1974;

Three other studies using paired associate learning

tasks similar to the previously mentioned studies produced contradic
tory results with 45% to 70% of the subjects experiencing enhanced
learning while the other subjects experienced impaired learning or no
learning change (Swanson & Kinsbourne,
Roberts, & Zucker,

1978; Swanson,

1976; Swanson, Kinsbourne,

Sandman, Deutsch, & Baren,

1983).

Among the factors that could account for contradictory results are:
subtle differences in the task used to assess acquisition and differ
ences

in dosages administered to the subjects.

Unfortunately,

5
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standardized dosages (mg/kg) used in these studies were not reported.
Whatever the explanation for these conflicting results, their occur
rence provides one more reason for further investigation in this
area.
Several significant methodological problems surface when plan
ning a study on learning.

First,

the tasks used in within-subject

experimental designs must possess the same degree of difficulty
across repeated measures (Yoder & Fuqua,

1984).

In addition,

prob

lems with individual subject differences and dependence upon statis
tical analyses also arise, as do other problems generally encountered
in group designs (Hersen & Barlow,

1976; Sidman,

1960).

Many of

these problems appear to be eliminated when a within-subject experi
mental design is combined with a repeated acquisition procedure first
described by Boren in 1963 (Thompson,

1973).

Since 1963,

many

studies have evaluated the effects of various drugs on learning using
this procedure (Handley & Calhoun,
Walker,

1982; Yoder & Fuqua,

1978; Thompson,

1973,

1976;

1984).

Thompson (1976) used the repeated acquisition procedure to
assess the effects of methylphenidate and imipramine (Tofranil) on
learning and performance in three pigeons.

The pigeons' task was to

peck the correct key when the three response keys were illuminated
with a given color so as to successfully complete a 4-response chain
and receive reinforcement.
5-second time-out followed.

When an incorrect response occurred, a
After stable error rates were reached,

the drugs were administered and their effects on learning and per
formance recorded.

From the obtained results the author concluded
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that methylphenidate impaired learning at each dose tested (2.5,

5,

10, and 20 mg/kg) whereas performance was unaffected at all doses
except the highest.

This adds further evidence for the hypothesis

that different dose-response relations exist for different target
behaviors (i.e., acquisition vs. performance) with respect to methyl
phenidate .
Walker (1982) extended Thompson's (1976) work by using the
repeated acquisition task to assess the effects of methylphenidate on
learning in hyperactive children.

The subjects were instructed to

learn three different six-component behavioral chains associated with
three discriminative stimuli.

When the subject completed five chains

(FR-5), a point was delivered and appeared on the computer screen
being used by the subject.

When an error occurred, a time-out was

enacted and the screen went blank for 2 seconds after which the
subject was returned to the same link in the chain.

Walker (1982)

looked at the effects of 0.3 and 0.7 mg/kg of methylphenidate and a
placebo condition on the rate of learning (number of errors and
response rate).

Through statistical analyses of the data,

the author

concluded that both doses enhanced learning (decreased error rate and
increased response rate) significantly with the highest dose having
the greatest effect.
Walker's

(1982) results are in contrast to Thompson's (1976)

study which concluded that all doses of methylphenidate impaired
learning.

Possible explanations for this include species and m e t h 

odological differences (Walker,

1982; Yoder & Fuqua,

1984).

These

results also conflict with Sprague and Sleator's (1977) conclusion

'V
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that 0.3 mg/kg produces the optimal improvement in short-term memory.
This conflict m a y be explained in terms of different dose-response
curves for learning and m e m o r y when methylphenidate is used, or since
0.7 mg/kg is between the doses tested by Sprague and sleator (1977)
(0.3 and 1.0 mg/kg),

the results actually m a y not be in conflict at

all (Yoder & Fuqua, 1984).
In the most recent study to assess the effects of methyl
phenidate on learning and performance,

Yoder and Fuqua (1984)

evaluated four hyperactive children with a repeated acquisition task
that included learning and performance components.

In addition,

hyperactivity was also assessed with the Connor's Abbreviated Teach
ers Rating Scale (CATRS) weekly and classroom academic measures were
monitored for two of the subjects.
(subject's current therapeutic dose,

Three methylphenidate dosages
5 mg/kg higher,

and 5 mg/kg

lower) and one placebo condition were evaluated during this study.
The repeated acquisition task required the subject to complete a sixcomponent chain by choosing the appropriate chip from each of six
groups of three.

A 5-second time-out was enacted for each selection

error during which the display board was covered.

The subject was

returned to the same link in the chain after the time-out had ex
pired.

Reinforcement occurred upon completion of a response

sequence.

Points earned in this manner could be exchanged for dimes

or video game tokens at the end of the sessions.

Learning and per

formance components were conducted during each session with the
learning task occurring first.

A new response chain was created for

each session in the learning component, whereas the task remained the
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same for the performance component throughout the experiment.

The

authors concluded that methylphenidate neither impairs nor enhances
learning and performance.

The academic measures monitored for two of

the subjects improved under placebo conditions and CATRS scores
generally decreased as the dosage increased.

This supports the

theory that different target behaviors have varying dose-response
relations (Brown & Sleator,
Sleator,

1977; Walker,

1979; Sleator & Sprague,

1982).

Also,

1974; Sprague &

the data from this study are in

conflict with Thompson's (1976) conclusion that methylphenidate
impairs learning and Walker's (1982) results indicating enhancement
of learning with methylphenidate.

Many explanations m a y be offered

for this occurrence including species and methodological differences
in the former and subject and methodological differences in the
latter.

In addition,

the results of the Yoder and Fuqua (1984) study

should be interpreted cautiously because of the high degree of vari
ability seen throughout the data and the low error rates and high
response rates generated by the repeated acquisition task prior to
contact with the independent variable.

The detection of a drug

effect on learning as reflected in a reduction in errors may have
been prevented because of the low error rates that occurred in the
study.
When the popularity of methylphenidate as a treatment for hyper
activity in school-aged children is considered along wi t h the con
flicting results obtained from learning studies so far, it is clear
that this is an area requiring further assessment.

This study ex

tended Yoder and Fuqua's (1984) study by using a more difficult

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

repeated acquisition task.

Dependent variables included error rates

on the learning and performance components of the repeated acquisi
tion task and hyperactivity ratings obtained from the CATRS with the
intent to determine the effects methylphenidate has on learning and
performance in a child with ADDH.
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CHAPTER III

METHODOLOGY

Subject Selection and Setting

Several community based pediatricians were contacted by mail and
phone and asked £or their help in the recruitment of subjects.

They

were informed of the study's intent and format and provided with
criteria that the potential subjects needed to meet prior to inclu
sion.

These criteria included:

(a) a diagnosis of ADDH,

(b) ages

6-12, and (c) have been taking Ritalin for a m i n i m u m of 3 months.
The physicians sent letters to over 25 potential participants and
contacted many others in person; however, only two interested parents
contacted the experimenter.

Both of the potential subjects fulfilled

the criteria listed earlier and were selected to participate.
fortunately,

Un

one of the children developed a significant health

problem and was withdrawn 3 days prior to the start of the experi
ment .
The purposes of the study were explained to the subject's
mother, the procedure was demonstrated, and informed consent was
obtained prior to the start of the study (Appendix A).

In addition,

the procedure was explained to the subject, Patrick, who then agreed
to participate willingly.

Patrick was 7 years old and attended a

normal first grade class at the time of the experiment.

He had a

history of attentional and behavioral problems in school and had been

11
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on Ritalin for at least one year.
The procedure was conducted in a room at the subject's school
which contained two tables, a blackboard, and 10 chairs.

The other

data were obtained by the teacher in the classroom setting.

Apparatus and Other Materials

The repeated acquisition apparatus was made of two pieces of
1/8 inch thick hardboard 22 inches long and 18 inches wide.

The top

piece had seven rows of six round holes each cut into it and was
secured to the second piece of hardboard with glue.

The diameter of

the holes was 1 3/4 inches, sufficiently large to enable a poker chip
to fit loosely into them and be taken out easily.

Rows of chips were

separated by 1 1/2 inches

and chips within each r ow were 1 inch

apart.

rivets secured 1 inch from the edge Con the

There were copper

left and right sides of the apparatus) between the rows, above the
first row and below the sixth row.

This enabled an 18 1/4 inch by

2 3/4 inch piece of hardboard to be slid across each of the first six
rows to prevent the subject from viewing the rows not currently being
worked on.

It also functioned as a discriminative stimulus and was

used to indicate which of the six rows was the appropriate one in
which to make a response.

The first six rows contained six white

poker chips, with each chip possessing a 1/2 inch by 3/4 inch colored
sticker on the bottom side in one of six colors
yellow, blue, orange, and

red).

(purple, green,

The seventh row remained

empty until

the procedure was in process.
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Poker chips and a jar were used by the experimenter during the
sessions to provide immediate reinforcement to the subject upon
completion of a sequence.

Back-up reinforcers were decided upon

prior to the start of the experiment by a joint decision between the
experimenter,

the subject,

and the subject's mother.

The subject

exchanged the poker chips earned in the day's session for video game
tokens.

A card was written out each day informing the mother h ow

many chips were earned, h o w many video game tokens should be re
ceived, and h o w many chips were carried over to the next testing day.
In general,

the tokens were delivered reliably; however, occasionally

Patrick reported that his mother "owed" h im a specific number of
tokens but he consistently reported receiving these tokens within 2
days of the sessions in which they were earned.

Data Collection and Reliability

Data were collected on the number of errors during both the
learning and performance components.

Errors were defined as an

incorrect choice of a chip, choosing a chip from an unexposed row,
and no response at all by the subject within 5 seconds after a row
had been exposed.

The position of the errors was also recorded so as

to detect any position preferences.
The experimenter used data sheets (Appendix B) on which was
recorded when and where each error occurred,

the total number of

responses, the number of incorrect and correct responses, and the
elapsed time for the specific component.
during every session,

These data were collected

for the entire session.
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The reliability observer, a professional wi t h an advanced degree
in human services,

was trained on the recording procedure prior to

encountering the actual subject in the experimental setting.

The

observer practiced scoring the procedure during several demonstra
tions until it could be done quickly and accurately, without any
errors committed.
Interobserver agreement checks were conducted in a nonblind
fashion on every fourth day throughout the entire experiment for a
total of eight sessions (23% of the total number of sessions).

The

observer sat behind and to the right of the subject with a clear v i e w
of the subject and repeated acquisition apparatus.

The observer

recorded the subject's behavior in the same manner as the experi
menter.
nated.

These records were compared after the session had termi
Percentage agreement was determined by the following formula:

agreements on the occurrence of an error by the subject/agreements +
disagreements x 100.

There was 100% agreement between the experi

menter and observer on the occurrence of each error committed by the
subject on a trial-by-trial basis.
Hyperactivity ratings were obtained from the Connor's Abbre
viated Teacher's Rating Scale (CATRS) which was completed by the
subject's teacher.

These ratings occurred once each week on Friday

and reflected the subject's morning behavior for the entire week.
Academic measures were not available as no assignment was given to
the subject on a daily or regular basis.
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Procedure

For this study the independent variable was the subject's m o r n 
ing dose of methylphenidate.

This was the therapeutic dose that the

subject was prescribed and taking prior to the study.

Other doses

tested throughout the experiment included 5 m g higher than the base
line dose, 5 m g lower, and a placebo condition.
The stimulant medication was delivered to the parents every
Friday in sealed and dated envelopes.

Since placebos could not be

located for the Ritalin, another method to prevent the subject and
others involved from determining what dosage of medication was being
given was utilized.

Each envelope contained the appropriate dosage

of methylphenidate ground to a powder in addition to a specific
amount of a neutral substance, vitamin B-l.

During the placebo phase

the subject received only the ground up vitamin.

Enough B-l was

combined with every dose of methylphenidate so that the powder in
each envelope during each phase was approximately the same and the
taste of the Ritalin could not be detected.

The subject was adminis

tered the medication in a water solution on a spoon and followed it
with a glass of water.

Only the experimenter was aware of the dosage

changes when they occurred;
dose changes,

all others involved were only aware that

if they occurred, would occur over the weekend.

The

parents were responsible for insuring that the medication was a dmin
istered each morning.
Because of the short biologically active life of methyl
phenidate,

the sessions occurred 2 hours after ingestion of the drug
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(Oettinger & Majovski,

1976;

Swanson et al., 1978).

The sessions

occurred at the same time each day and lasted no longer than 30
minutes (20 minutes for the learning component and 10 minutes for the
performance

component).

Throughout the study the subject
experimenter and the apparatus was

was seated across from the

on the table between them.

seventh (empty) row was nearest to the subject.

The

The jar and poker

chips delivered upon completion of the response sequence were on the
experimenter's left and the data sheets were attached to a clipboard
and kept

from the subject's view.

The subject was instructed toselect
six (starting with the row closest
believed to be correct.

the chip in each group of

to the experimenter) that he

If the selected chip was correct,

the sub

ject placed that chip into the position in the seventh row that
corresponded to the row from which the chip was selected (e.g., the
chip from the first row went in the first position of the seventh
row,

the chip from the second row went in the second position of the

seventh row,

etc.).

Upon completion of the entire response sequence,

the subject received a chip for its completion and two chips if it
was completed without any errors.

A short, simple statement of

a p p r o v a l (e.g., "That's right," "You're c o r r ect," etc.) w as v o i c e d by
the experimenter when the correct chip was chosen.

When an error was

made (wrong chip chosen, no chip chosen within 5 seconds after a row
had been exposed, or chip chosen from an unexposed row) the experi
menter said,

"No,

that's not right."

The subject then replaced the

chip in its original position and chose another chip.

When a
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sequence was completed, one or two chips (based on the accuracy of
the subject's performance) were deposited in the jar, the chips were
replaced in their original positions in v i e w of the subject, and the
sequence

started over.

As mentioned earlier, each session included a learning and
performance component which lasted 20 and 10 minutes,
and consisted of 10 trials each.

respectively,

The learning component included a

new response sequence every day and the performance component had the
same sequence throughout the study.

Upon completion of the learning

component the experimenter placed the chips in the correct sequence
in the apparatus for the performance component.

Prior to the start

of each component the subject was informed whether he was working on
a novel sequence or the one that he knew.
The response sequences used in the study were determined during
the preexperiment sessions and the ones chosen generated 10 or more
errors per session for at least 5 sessions (to insure a difficult
task).

The sequences were randomly generated with the following

restrictions:

(a) a g i v e n p o s i t i o n (1, 2, 3, 4, 5, or 6) c o u l d not

be repeated consecutively within a chain;

(b) for a given link of the

six-link chain, the same position could not be designated as correct
for more than two consecutive sessions; and (c) a given two-link
sequence (i.e., 1 and 4) could not appear more than once within a
s ingle chain.
The preexperiment sessions lasted 10 days and instructions and
reverse chaining were used to train the subject on the experimental
task.

The subject earned chips initially for turning over the last
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chip in the sequence,

then the last two chips, etc. until the entire

sequence was completed.

Criterion for mastery of the performance

component was 100% co.rect sequence completion on 10 trials over 2
consecutive days.

The experiment started when the performance compo

nent was mastered and the number of errors in the learning component
was

stable.

Experimental Design

The study consisted of five phases:

(a) baseline (0.23 mg/kg),

(b) h i g h e r (0.34 mg/kg), (c) l o w e r (0.11 mg/kg), (d) p l acebo, and
(e) baseline.

The preexperiment training occurred prior to the ini

tial baseline phase with the subject receiving the baseline dose of
medication.

Except for the initial training,

the procedure during

all phases was conducted in the same manner.
Each phase lasted at least 5 days with a change to the next
phase being determined by visual inspection of the data, degree of
variability,

and the amount of the school year left.

v
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CHAPTER IV

RESULTS

Figure 1 shows Che number of errors per session for the subject
in both the learning and performance components of the experiment.

.23

.34

.23

• -LEARNING
n-KNEORMANCE
B ~ RELIABILITY

SESSIONS

Figure 1.

Number of Errors per Session for the Learning and Perform
ance Components at All Dosage Levels Tested.
19

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

20
An extreme amount of variability was seen within and across all
phases with only the data during the decreased dosage phase approach
ing stability.

The first baseline phase showed the largest degree of

variability with the range of errors being 19-102.

No stable changes

were seen in the number of errors or trends within phases when dosage
changes occurred.

At the start of each n e w phase there was a very

evident initial change in the errors per session from the previous
phase; however,
entire phase.

these changes were not maintained throughout the

A slight upward shift of the data was evident in the

placebo phase as compared to the other medication phases (excluding
the initial baseline phase).

No errors occurred during the perform

ance component until the second baseline wh e n one error occurred on
two different occasions.
Figure 2 shows the mean errors per session at each dosage level
tested for each of the experimental components.

Errors during the

learning component always exceeded those that occurred during the
performance component at all dosage levels.

The brackets represent

one standard deviation and depict the high degree of variability in
the error rate that was present within each phase.

Relatively small

differences between the data for each phase suggests the absence of a
strong drug effect on learning.

Again, when the initial baseline was

disregarded and the other data viewed,

the me a n errors during the

placebo phase slightly exceeded those in the other phases.

W h e n the

data are rearranged by dGsage, from the smallest to the largest, a Ushaped curve is formed as the placebo and highest doses have greater
mean error rates than the baseline and lower doses (when the initial
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baseline is not considered).

This curve is similar to that obtained

on the dose-response effects of methylphenidate on short-term m e m o r y
(Sprague & Sleator,
Bailey,

1982),

1977), on problems completed (Rapport, Murphy,

and on learning (Yoder & Fuqua,

&

1984).
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Figure 2.

Mean Number of Errors per Session in Both Learning and
Performance Components at Each Given Dosage.

Figure 3 shows the mean errors per trial, a measure of within
session learning,

for each phase.

The majority of errors occurred on

the first trial when guessing was required.

After than, the errors

decreased rapidly and approached zero by the fourth trial in three of

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

22
the phases.

Errors in the first baseline phase never went below one

and errors during the placebo phase were mu c h more variable and did
not approach zero until the seventh trial.

.23

.34

.23

15-

i/i

5-

0-

TRIALS

Figure 3.

Mean Number of Errors per Trial in the Learning and Per
formance Components at Each Given Dosage.

The classroom measures of hyperactivity provided by the sub
ject's teacher are displayed in Figure A,

Patrick never received a

score on the CATRS that fell in the hyperactive range of the scale.
The highest score occurred during the initial baseline phase and the
lowest score occurred during the second baseline phase.

It should be
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noted that both the initial baseline and placebo scores are the
product of one weekly score,

whereas the other three scores are the

means of two weekly scores.

3025-

5

20

"

U
i

.23

.34

.11

PL

.23

DOSAGE ( M g / K g )
Figure 4.

Mean Scores on the CATRS at Each Dosage Level.
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CHAPTER V

DISCUSSION

The results of this study suggest that methylphenidate, at the
dosages tested, neither impairs nor facilitates learning in children
diagnosed ADDH.

Of course,

this conclusion should be interpreted

cautiously because of the high degree of variability that was pres
ent, the single subject design, and the limited range of doses
tested.

However, these results are in agreement with the conclusions

of the Yoder and Fuqua (1984) study that looked at the effects of
methylphenidate on learning and performance in four subjects.
with the Yoder and Fuqua (1984) study,

As

this experiment's results are

in contrast with the results obtained in Walker's (1982) study with
humans and Thompson's (1976) study with pigeons.

The author of the

first study concluded that both doses tested (0.3 and 0.7 mg/kg)
enhanced learning significantly with the highest dose having the
greatest effect.
doses (1.5, 5,

The latter study investigated a wider range of

10, and 20 mg/kg) and concluded that methylphenidate

impaired learning of pigeons at each dose tested,
was unaffected at all doses except the highest.

whereas performance
There are several

explanations available for the contradictory results.

These include

species differences in the case of the current study compared to
Thompson's (1976) study,
methylphenidate tested.

as well as the widely differing dosages of
Also,

Walker's (1982) initial data were

24
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barely significant so a statistical analysis was performed to trans
form the data and make the results appear more significant.

There

were also many methodological differences between the three studies.
Even though a high level of variability was present throughout
the data, the occurrence of a slight, inconsequential drug effect m ay
be argued.

This is suggested in Figure 3 as the placebo phase curve

is more variable and approaches zero at a trial beyond which three of
the other four phases have approached it.

Figure 1 also suggests the

same effect as the data in the placebo condition are shifted slightly
upward as compared to the other phases (excluding the initial base
line phase).

In addition,

this slight effect m ay be demonstrated in

the second figure as the mean errors per session is the highest
during the placebo condition.
variability in the data,

However,

given the high level of

the small number of data days comprising the

placebo condition, the overlapping of data points between the placebo
phase and the other phases,

and the subject's inconsistent perform

ance in the baseline phases, the conclusion that a small drug effect
exists should be drawn with extreme caution.
As mentioned earlier, the U-shaped curve evident in Figure 2
when the data are rearranged (PL, 0.11, 0.23, 0.34) is similar to
short-term m e m o r y curves obtained by Sprague and Sleator (1977),
dose-response effects of methylphenidate on learning obtained by
Yoder and Fuqua (1984), and problems completed curve obtained by
Rapport et al. (1982).

This conclusion should be made with extreme

caution as the dosages tested in this study fell at the lower range
of dosages tested in the previously mentioned studies.

In the
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current study, the mean errors per session during the low dosage
condition is less than the me a n errors present in the placebo and the
high dosage condition.

Compilation of these data imply that there is

an optimal dose of methylphenidate for learning measures and that
varying from this dose would have an undesirable effect on the learn
ing measure.

It can be extrapolated further that there is a neces

sity for physicians to investigate the effects of several dosages of
methylphenidate on social and cognitive measures with each child
prior to prescribing a maintenance dose of the medication as the
optimal dosage of the medication m ay vary for different target behav
iors .
Variability was most obvious during the initial baseline phase
despite the rigorous attempts to ensure a stable testing situation.
It is unknown exactly what caused the high degree of variability but
a few possibilities exist.

This phase occurred right after the

subject's spring break and the variable data m a y have been due,
part,

in

to the subject's difficulty in settling d o w n after being off

from school for a week.

Patrick also cried very often during this

phase for no reason apparent to the experimenter.

The experimenter

discussed the situation with Patrick's teacher and mother.

Both

agreed that Patrick had been more emotional and unpredictable than
usual but no specific reason could be identified.

This is also the

condition in which Patrick received the highest hyperactivity score
on the CATRS.

Ideally,

this phase should have been extended until

the data were less variable.

Unfortunately,

the teacher's and

mother's concern regarding Patrick's behavior and the remaining

' V
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school year were determinants of the phase change occurring when it
did.
The CATRS,

completed weekly by the teacher, is a measure of

questionable reliability and validity as it involves a subjective
rating scale.

In this study the measure did not appear sufficiently

sensitive to adequately represent Patrick's morning behavior.

Even

though Patrick received the highest scores in the first baseline and
placebo conditions, both scores fall well below the hyperactive level
on the scale (15).

During the placebo phase the subject was very

difficult to keep on task and was frequently moving about the room or
playing with the chairs.

The teacher also commented at this time

that he spoke out of turn often and was uncooperative.

What occurred

during the testing sessions indicated a much higher score on the
CATRS than what was received.

With this under consideration, the

sensitivity and validity of the CATRS is in question, as well as the
reliability of the teacher's ratings and her sensitivity to the
child's morning behavior.

It can also be questioned whether the

child is hyperactive; however,

a diagnosis of ADDH by a pediatrician,

subjective observations made by the experimenter during the study,
and reports from the mother indicate otherwise.
In terms of variability and highest error rates, the placebo and
first baseline conditions far surpassed the other three conditions.
It should be noted that these conditions only lasted 5 days each
compared to the other conditions which lasted 7 to 9 days.

The

possibility exists that more data during these conditions ma y have
reduced the variability so m u c h more evident in these two phases as
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well as affected the CATRS scores obtained during these phases also.
There are several areas in which this research could be improved
upon in the future.

First,

the data are less variable.

all the phases should be extended until
This would allow any drug effects to be

seen more clearly and conclusions could be drawn with more confi
dence.

Second, academic measures that occur on a daily basis and

are of a standard difficulty and representative of other academic
tasks should be included as an indicator of the effects methyl
phenidate has on actual classroom measures of learning.

These m e a 

sures were not available for this study as no academic measure
occurred in the morning on a daily basis for the subject.

Also,

these measures should be correlated with the repeated acquisition
procedure to

determine if the procedure is comparable enough

to

enable it to be used us a valid indicator of the effects various
medications have on learning measures used in the classroom.

In

addition, research investigating the effects of a wide range of
dosages on various target behaviors is needed to further assess doseresponse relations.
be gradually

Lastly,

faded out

the tokens used in the experiment should

at the end of the experiment in order to

determine if they were maintaining the subject's responding.

Since

tokens are not frequently used in a classroom setting, this is an
important area for investigation.
The findings of the present study concur with those of Yoder and
Fuqua (1984) that methylphenidate neither impairs nor facilitates
learning and performance as measured by the repeated acquisition task
in children diagnosed ADDH.

Considering the contrasting findings
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existing in this area, it is clear that there is more research to be
done on the effects of Ritalin.
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Informed Consent Form

We, _________________________________________________ , the parents of
____________________________________________ , authorize the experimenter
to include our child in a study of the effects of methylphenidate on
learning and performance.

A repeated acquisition procedure will be

used in the study which will require the child to complete a response
sequence consisting of six components.

The dose of methylphenidate

currently being taken by the child will be altered occasionally
during the study (increased by 5 mg/kg, decreased by 5 mg/kg, and
replaced by a placebo).
weeks each.

These changes should not last more than 2

We agree to continue giving the medication as prescribed

throughout the study and will inform the experimenter prior to any
necessary changes.
This study is understood to provide minimal risk to the child as
the apparatus to be used will be similar to a store bought game
board,

the planned dosage changes have not been reported to produce

any adverse reactions, and the child will not be taken out of his/her
classroom during programmed instruction.

Benefits to the child ma y

result from the one-on-one interactions with an adult each day during
the study.

These may include an increased sense of self-importance

and self-esteem because of inclusion in the study and added attention.
W e also understand that we have the right to question the
experimenter concerning the study and the child's role in it and that
we can remove our child at any time from the study.

Furthermore, any

information obtained from the study will be confidential.

By signing
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this form we understand that the data m a y be used in scientific
presentations and publications and that all identifying information
will be removed so that the child's identity will remain confidential.
Your signatures below indicate that you have read and understood
the above information and decided to allow your child to participate
in the study.

You will be given a copy of this form to keep.

Signed

Signed

Witnessed

Dated

'V
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Recording Form

/
experimenter

subject

/

date

:
start

___
end

Trial

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

1.

Total # responses __ ______
(incorrect & correct)

o

2.

Total # of errors _________

o

o

3.

o

o

o

Component t i m e _______ min.
(end - start)

o

o

o

o

o

o

o

o

o

O

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

O

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

□

o

o

o

o

o

o

o

o

Trial

correct sequence

Trial

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Recording Form (page 2)

/
subject

experimenter

Trial

/
end

start

date

Trial

O

o

o

o

o

o

O

o

o

o

o

o

O

o

o

o

o

□

o

o

o

o

o

o

o

o

o

o

o

o

o

□

o

o

o

o

□

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

Trial

Trial

O

o

o

o

o

o

O

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

□

Trial

Trial

O

o

o

□

o

o

O

□

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

□

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

□

o

o

o

o

o

□

o

o

o

o

o

o

o

o

o

o

o

correct sequence
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